Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Nanomedicine conference to discuss the changing practice of healthcare and challenges in integrating nanotech into established business models

Abstract:
The Institute of Nanotechnology, global leader in nanotechnology information services, is organising its second annual nanomedicine conference and exhibition which will showcase the latest developments in medical nanotechnologies and potential routes to finance. The two day event will see leading multinational companies, such as Philips, AstraZeneca, GE Healthcare, GlaxoSmithKline, Volcano Corporation and Fresenius Medical Care, sharing their vision of the impacts of nanomedicine on healthcare and providing a window on their activities.

Nanomedicine conference to discuss the changing practice of healthcare and challenges in integrating nanotech into established business models

London, UK | Posted on November 20th, 2007

Key discussions will be on the changing practice of healthcare, challenges in integrating nanomedicine into established business models, managing ‘risks and uncertainties' , the role of public-private partnerships in building value, requirements for better regulation and standardisation as well as the barriers to the clinic. The conference will also have three main technology sessions, 'Drug Delivery and Pharmaceutical Development', ‘Tissue Engineering and Regenerative Medicine' and 'Novel Devices, Nanosensors, Diagnostics and Imaging'.

The Head of ‘Nanosciences and Nanotechnologies' unit at The European Commission will outline the EC's nanomedicine plan and how some of the €800million dedicated under FP7 will be targeted towards new nanotechnology-based treatments. The Wellcome Trust will present details about their funding priorities and new technology transfer initiatives and EMEA will summarise their views on regulatory hurdles. The conference will also see a number of innovative small companies' presenting novel nanomedical technologies and presentations from top scientists as far away as India and Malaysia. The associated exhibition will showcase new innovations in nanomedicine and provide a unique opportunity to network with potential partners.

Investing in Medical Nanotechnology II builds upon the success of the inaugural event held last year to bring the latest developments in the exciting and dynamic new field of nanomedicine. The event sponsored by Marks & Clerk, MTI Partners and Tinytech Jobs will take place on 28-29 November at the historic and prestigious Royal College of Surgeons in London. Further details are available at http://nanomednet.org/conference07/ or alternatively contact Tiju Joseph at the Institute of Nanotechnology on +44 (0) 141 330 8734.

####

For more information, please click here

Contacts:
Tiju Joseph

+44 (0) 141 330 8734

Copyright © Institute of Nanotechnology

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

JPK’s NanoWizard AFM system is being used for cell studies in the Research Centre for Nanometer-scale Science & Advanced Materials at the Jagiellonian University in Krakow, Poland May 31st, 2016

Nanobiotix receives US$1m milestone payment from PharmaEngine: First patient injected with NBTXR3 in soft tissue sarcoma registration phase in Asia May 31st, 2016

Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology May 31st, 2016

Automating DNA origami opens door to many new uses: Like 3-D printing did for larger objects, method makes it easy to build nanoparticles out of DNA May 30th, 2016

Announcements

JPK’s NanoWizard AFM system is being used for cell studies in the Research Centre for Nanometer-scale Science & Advanced Materials at the Jagiellonian University in Krakow, Poland May 31st, 2016

Nanobiotix receives US$1m milestone payment from PharmaEngine: First patient injected with NBTXR3 in soft tissue sarcoma registration phase in Asia May 31st, 2016

GLOBALFOUNDRIES to Expand Presence in China with 300mm Fab in Chongqing: Company plans new manufacturing facility and additional design capabilities to serve customers in China May 31st, 2016

Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology May 31st, 2016

Events/Classes

Novel gene therapy shows potential for lung repair in asthma May 18th, 2016

Arrowhead Pharmaceuticals' Preclinical Candidate ARC-LPA Achieves 98% Knockdown and Long Duration of Effect after Subcutaneous Administration May 10th, 2016

Nanometrics Announces Upcoming Investor Events May 10th, 2016

Oxford Instruments Asylum Research and McGill University Announce the McGill AFM Summer School and Workshop, May 12-13, 2016 May 4th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic